First Time Loading...

Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 9.19 USD -2.23% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

ACCD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Accolade, Inc. engages in the provision of personalized health and benefits solutions. [ Read More ]

The intrinsic value of one ACCD stock under the Base Case scenario is 16.47 USD. Compared to the current market price of 9.19 USD, Accolade Inc is Undervalued by 44%.

Key Points:
ACCD Intrinsic Value
Base Case
16.47 USD
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Accolade Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling ACCD stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Accolade Inc

Provide an overview of the primary business activities
of Accolade Inc.

What unique competitive advantages
does Accolade Inc hold over its rivals?

What risks and challenges
does Accolade Inc face in the near future?

Has there been any significant insider trading activity
in Accolade Inc recently?

Summarize the latest earnings call
of Accolade Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Accolade Inc.

Provide P/S
for Accolade Inc.

Provide P/E
for Accolade Inc.

Provide P/OCF
for Accolade Inc.

Provide P/FCFE
for Accolade Inc.

Provide P/B
for Accolade Inc.

Provide EV/S
for Accolade Inc.

Provide EV/GP
for Accolade Inc.

Provide EV/EBITDA
for Accolade Inc.

Provide EV/EBIT
for Accolade Inc.

Provide EV/OCF
for Accolade Inc.

Provide EV/FCFF
for Accolade Inc.

Provide EV/IC
for Accolade Inc.

Show me price targets
for Accolade Inc made by professional analysts.

What are the Revenue projections
for Accolade Inc?

How accurate were the past Revenue estimates
for Accolade Inc?

What are the Net Income projections
for Accolade Inc?

How accurate were the past Net Income estimates
for Accolade Inc?

What are the EPS projections
for Accolade Inc?

How accurate were the past EPS estimates
for Accolade Inc?

What are the EBIT projections
for Accolade Inc?

How accurate were the past EBIT estimates
for Accolade Inc?

Compare the revenue forecasts
for Accolade Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Accolade Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Accolade Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Accolade Inc compared to its peers.

Compare the P/E ratios
of Accolade Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Accolade Inc with its peers.

Analyze the financial leverage
of Accolade Inc compared to its main competitors.

Show all profitability ratios
for Accolade Inc.

Provide ROE
for Accolade Inc.

Provide ROA
for Accolade Inc.

Provide ROIC
for Accolade Inc.

Provide ROCE
for Accolade Inc.

Provide Gross Margin
for Accolade Inc.

Provide Operating Margin
for Accolade Inc.

Provide Net Margin
for Accolade Inc.

Provide FCF Margin
for Accolade Inc.

Show all solvency ratios
for Accolade Inc.

Provide D/E Ratio
for Accolade Inc.

Provide D/A Ratio
for Accolade Inc.

Provide Interest Coverage Ratio
for Accolade Inc.

Provide Altman Z-Score Ratio
for Accolade Inc.

Provide Quick Ratio
for Accolade Inc.

Provide Current Ratio
for Accolade Inc.

Provide Cash Ratio
for Accolade Inc.

What is the historical Revenue growth
over the last 5 years for Accolade Inc?

What is the historical Net Income growth
over the last 5 years for Accolade Inc?

What is the current Free Cash Flow
of Accolade Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Accolade Inc.

Financials

Balance Sheet Decomposition
Accolade Inc

Current Assets 272.1m
Cash & Short-Term Investments 230m
Receivables 25.6m
Other Current Assets 16.5m
Non-Current Assets 513.4m
PP&E 48.1m
Intangibles 452.7m
Other Non-Current Assets 12.6m
Current Liabilities 115.7m
Accounts Payable 12.7m
Accrued Liabilities 41.1m
Other Current Liabilities 61.9m
Non-Current Liabilities 235.1m
Long-Term Debt 208.2m
Other Non-Current Liabilities 26.9m
Efficiency

Earnings Waterfall
Accolade Inc

Revenue
388.5m USD
Cost of Revenue
-214.4m USD
Gross Profit
174.1m USD
Operating Expenses
-310m USD
Operating Income
-135.9m USD
Other Expenses
13.1m USD
Net Income
-122.7m USD

Free Cash Flow Analysis
Accolade Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

ACCD Profitability Score
Profitability Due Diligence

Accolade Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Positive Revenue Growth Forecast
29/100
Profitability
Score

Accolade Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ACCD Solvency Score
Solvency Due Diligence

Accolade Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
39/100
Solvency
Score

Accolade Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ACCD Price Targets Summary
Accolade Inc

Wall Street analysts forecast ACCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACCD is 15.37 USD with a low forecast of 12.12 USD and a high forecast of 18.9 USD.

Lowest
Price Target
12.12 USD
32% Upside
Average
Price Target
15.37 USD
67% Upside
Highest
Price Target
18.9 USD
106% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ACCD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ACCD Price
Accolade Inc

1M 1M
-8%
6M 6M
+39%
1Y 1Y
-43%
3Y 3Y
-82%
5Y 5Y
-69%
10Y 10Y
-69%
Annual Price Range
9.19
52w Low
6.5
52w High
16.06
Price Metrics
Average Annual Return -22.65%
Standard Deviation of Annual Returns 57.23%
Max Drawdown -91%
Shares Statistics
Market Capitalization 707.3m USD
Shares Outstanding 77 407 600
Percentage of Shares Shorted 4.25%

ACCD Return Decomposition
Main factors of price return

What is price return decomposition?

ACCD News

Other Videos

Company Profile

Accolade Inc Logo
Accolade Inc

Country

United States of America

Industry

Health Care

Market Cap

707.3m USD

Dividend Yield

0%

Description

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

Contact

WASHINGTON
Seattle
1201 Third Avenue, Suite 1700
+12069268100.0
https://www.accolade.com

IPO

2020-07-02

Employees

2 350

Officers

Chairman of the Board & CEO
Mr. Rajeev Singh
President
Mr. Robert Cavanaugh
CFO & Treasurer
Mr. Stephen H. Barnes CPA
Senior Vice President of Operations
Ms. Kristen Bruzek
Chief Accounting Officer
Mr. Colin McHugh
Senior Vice President of Investor Relations
Mr. Todd Friedman
Show More
Executive VP, General Counsel, CCO & Secretary
Mr. Richard Eskew
Chief People Officer & Senior Vice President
Ms. Kelsi McDonald Harris
Executive Vice President of Engineering
Mr. Drew Garner
Executive VP of Care Delivery, Chief Health Officer & Member of the Medical Advisory Board
Dr. Shantanu Nundy M.B.A., M.D.
Show Less

See Also

Discover More
What is the Intrinsic Value of one ACCD stock?

The intrinsic value of one ACCD stock under the Base Case scenario is 16.47 USD.

Is ACCD stock undervalued or overvalued?

Compared to the current market price of 9.19 USD, Accolade Inc is Undervalued by 44%.